I want justice today. I want the judge to reject the plea.
This week, Purdue Pharma — the company that put OxyContin into the American bloodstream — ceases to exist, dissolved by the weight of a legal settlement spanning decades of grief and more than nine hundred thousand deaths. A fifty-billion-dollar agreement redistributes wealth and funds public health efforts, while the Sackler family, which built its fortune on the drug's proliferation, contributes up to seven billion over fifteen years. Yet outside the courthouse in Newark, families holding paper headstones asked a question that no settlement can answer: when money changes hands but no one goes to prison, has justice actually arrived?
- Purdue Pharma's dissolution this week closes a chapter on one of the most destructive corporate legacies in American history, but for thousands of families, the wound remains wide open.
- A fifty-billion-dollar settlement sounds monumental until individual victims learn their share: between eight thousand and sixteen thousand dollars for a lost child, a lost parent, a lost life.
- Outside Newark's federal courthouse, families carried paper headstones and photographs, their grief made visible in a protest that no legal filing could have anticipated or contained.
- Thirty-one survivors and bereaved family members addressed the judge directly, and nearly all of them asked him to reject the deal — not because they wanted more money, but because they wanted prosecution.
- The bankruptcy judge approved the settlement anyway, leaving the question of criminal accountability suspended in the air as Purdue's corporate shell quietly disappears.
By the end of this week, Purdue Pharma will cease to exist. In its place will rise a public-benefit entity — a transformation born not from innovation, but from a legal reckoning that consumed years, billions in fees, and more than nine hundred thousand American lives since 1999.
The settlement's architecture is staggering on paper. The Sackler family has agreed to contribute up to seven billion dollars over fifteen years. The federal government extracted over eight billion in forfeitures and penalties from the company itself, though it agreed to collect only a fraction in exchange for Purdue reaching separate agreements with states, cities, Native American tribes, and others. A Purdue lawyer acknowledged that the lawsuits against the company totaled over forty trillion dollars in claimed damages. Individual victims will receive between eight thousand and sixteen thousand dollars each. The remainder flows to government entities for overdose prevention and treatment.
But numbers do not capture what happened on a Tuesday in front of Newark's federal courthouse. Families of the dead gathered holding paper headstones bearing photographs of their relatives. One woman spoke of a son who died on Presidents' Day in 2001. Another described how OxyContin led her child from prescription pills to heroin to fentanyl. Tiffineee Baker stood among them, still carrying the loss of her twenty-six-year-old son. "There's no words to describe how hard this loss has been," she said.
Inside, thirty-one people addressed the judge directly. Michele Wagner described finding her son Mitchell in a store bathroom after an overdose — his boots visible on the floor, alive when she arrived, dead within the hour. Another mother had lost two children. Almost all of them asked the judge to reject the settlement. They did not want a financial arrangement. They wanted prosecution. "I want justice today," said Edward Bisch, whose son also died. "I want the judge to reject the plea and the DOJ to do their job."
The judge approved the settlement regardless. As Purdue Pharma dissolves, the tension between a deal that moves money and a hunger for accountability that moves nothing but the law remains, for these families, entirely unresolved.
By the end of this week, Purdue Pharma will cease to exist as a company. In its place will rise an entity designed to serve the public good—a transformation born not from innovation or market forces, but from a legal reckoning that has consumed years and billions in court fees. The dissolution marks the formal end of a settlement that, on paper, looks enormous: more than fifty billion dollars flowing toward addressing the opioid epidemic that has killed over nine hundred thousand Americans since 1999.
The numbers tell one story. The Sackler family, which owns Purdue, has agreed to contribute up to seven billion dollars over the next fifteen years. The federal government negotiated a guilty plea that extracted eight point three billion in forfeitures, fines, and penalties from the company itself, though the government agreed to collect only two hundred twenty-five million of that in exchange for Purdue reaching separate settlements with the thousands of lawsuits filed by states, cities, Native American tribes, and other groups. A Purdue lawyer acknowledged that the lawsuits against the company—the ones that did include specific financial demands—totaled over forty trillion dollars in damages. Individual victims are expected to receive between eight thousand and sixteen thousand dollars each. The rest of the money will go to government entities to spend on overdose prevention and treatment.
But numbers do not capture what happened on a Tuesday in front of Newark's federal courthouse, where families of the dead gathered holding paper headstones with photographs of their relatives. One woman spoke of her son, who died on Presidents' Day in 2001. Another described how OxyContin led her child to heroin and then to fentanyl. Tiffineee Baker stood among them, still carrying the weight of losing her twenty-six-year-old son to fentanyl poisoning after he became addicted to prescription pills. "There's no words to describe how hard this loss has been," she said.
Inside the courthouse, thirty-one people were permitted to address the judge directly, some in person and others remotely, to speak about what they had endured. Michele Wagner was among them. She described her son, Mitchell Harper, who died in 2014. She believed he had become a heroin addict after using prescription drugs. She told the judge about finding him after an overdose in a store bathroom, about seeing his boots on the floor, about how he was alive when she arrived and dead within the hour. Another mother spoke of losing two children to opioid addiction. Others described their own struggles with addiction.
Almost all of them asked the judge to reject the settlement. They did not want a financial arrangement. They wanted accountability. Edward Bisch, whose son died, was direct: "I want justice today. I want the judge to reject the plea and the DOJ to do their job and prosecute." The tension in that courtroom—between a settlement that moves money and a hunger for prosecution that moves nothing but the law—remains unresolved. The bankruptcy judge approved the broader settlement in November after years of legal maneuvering and more than a billion dollars in legal fees. Now, as Purdue Pharma dissolves, the question of whether this constitutes justice or merely a transaction hangs in the air.
Notable Quotes
There's no words to describe how hard this loss has been.— Tiffineee Baker, mother of a 26-year-old who died of fentanyl poisoning
I saw his boots. My son was alive when I got there, and within the hour, he wasn't.— Michele Wagner, describing finding her son Mitchell Harper after an overdose
The Hearth Conversation Another angle on the story
Why does a company dissolve rather than face criminal charges?
Because the settlement was negotiated between Purdue's lawyers and the government. A guilty plea was part of it, but the company itself doesn't go to prison. It becomes something else—a trust focused on public health. The Sackler family keeps their wealth mostly intact, though they're contributing billions.
And the families who lost people—what do they get?
Eight to sixteen thousand dollars, depending on the claim. But most of the fifty billion goes to government agencies to spend on treatment and prevention. The families say that's not justice. They wanted criminal prosecution of the people who made the decisions.
Did anyone go to prison?
Not that the reporting shows. The guilty plea was the company's, not individuals'. That's what infuriates people like Michele Wagner, who watched her son die. She wanted someone held accountable in a way that money can't measure.
So the settlement is technically massive but feels hollow to the people most harmed?
Exactly. Fifty billion sounds enormous until you divide it among hundreds of thousands of dead and millions more struggling with addiction. And it sounds even smaller when you realize most of it goes to government budgets, not to the families themselves.
What happens to Purdue now?
It becomes a public benefit company. The idea is that instead of making profit for shareholders, it operates to address the crisis it helped create. Whether that actually happens, or whether it's just a legal fiction, remains to be seen.